risk markers
attributable risk
novel risk schemes
atrial fibrillation risk assessment
incident AF
enhanced risk prediction algorithm
contemporary risk scheme
imaging
distinct AF phenotypes
advanced electrocardiography
imminent AF epidemic
well-established prospective AF biobank
disease process
epidemiologic information
Novel multimodal approach
identification of targets
accumulated information
interdisciplinary exploitation of omics
tissue omics
clinical cohorts
Primary prevention efforts
independent information complementary
intermediate phenotypes
clinical practice
interdisciplinary team
international cohorts
chronic subclinical inflammation
unique prospective population
oxidative stress
structural remodelling
analyses strategies
autonomous tone
rapid translation
genomics
significant public health impact
systems biology integration
parameters representative of early stages
growing need
ground
expression
access
intervention
pathophysiological insights
cutting-edge technology
Gender
innovative tools
pathophysiology
proteomics
groups
specific focus
metabolomics
echocardiography
cardiac MRI
better understanding
Blood
discrimination
reversible changes
overall goal
ambitious concept
individualized treatment
results